Federation Des Caisses Desjardins Du Quebec Quidel Ortho Corp Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$41.76 - $74.73 $50,780 - $90,871	1,216 New	1,216 $58.3 Million
Q4 2023 Aug 14, 2024	SELL	$58.16 - $75.44 $955,336 - $1.24 Million	-16,426 Reduced 9.11%	163,937 $12.1 Billion
Q3 2023 Aug 14, 2024	BUY	$70.9 - $88.63 $12.8 Million - $16 Million	180,363 New	180,363 $13.2 Billion

Others Institutions Holding QDEL

# of Institutions

293

Shares Held

67.9M

Call Options Held

337K

Put Options Held

134K

T. Rowe Price Investment Management, Inc. Baltimore, MD

9.4M
Shares

$377 Million
0.26% of portfolio
Carlyle Group Inc. Washington, DC

8.26M
Shares

$332 Million
56.7% of portfolio
Vanguard Group Inc Valley Forge, PA

6.05M
Shares

$243 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$196 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

4.2M
Shares

$169 Million
5.33% of portfolio

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.69B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account